AU6904100A - Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene - Google Patents

Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene

Info

Publication number
AU6904100A
AU6904100A AU69041/00A AU6904100A AU6904100A AU 6904100 A AU6904100 A AU 6904100A AU 69041/00 A AU69041/00 A AU 69041/00A AU 6904100 A AU6904100 A AU 6904100A AU 6904100 A AU6904100 A AU 6904100A
Authority
AU
Australia
Prior art keywords
polymorphisms
immunoglobulin
chain gene
beta chain
drug target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69041/00A
Inventor
R. Rex Denton
Stefanie E. Kliem
Joel Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU6904100A publication Critical patent/AU6904100A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
AU69041/00A 1999-08-24 2000-08-11 Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene Abandoned AU6904100A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15042399P 1999-08-24 1999-08-24
US60150423 1999-08-24
PCT/US2000/022175 WO2001014588A1 (en) 1999-08-24 2000-08-11 Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene

Publications (1)

Publication Number Publication Date
AU6904100A true AU6904100A (en) 2001-03-19

Family

ID=22534457

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69041/00A Abandoned AU6904100A (en) 1999-08-24 2000-08-11 Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene

Country Status (2)

Country Link
AU (1) AU6904100A (en)
WO (1) WO2001014588A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0319135D0 (en) * 2003-08-14 2003-09-17 Isis Innovation Assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3156237B2 (en) * 1991-12-24 2001-04-16 雪印乳業株式会社 Anti-human IgE monoclonal antibody
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
WO1995005481A1 (en) * 1993-08-18 1995-02-23 Isis Innovation Limited Diagnostic method and therapy

Also Published As

Publication number Publication date
WO2001014588A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
ZA200200298B (en) C-Pyrazole A2A receptor agonists.
AU4058100A (en) Generic cdna or protein array for customized assays
AU4975300A (en) Dna melting curve analysis
AU5095000A (en) Receptor interacting protein rip3
AU5218700A (en) Conveyor transfer assembly
IL148266A0 (en) Apo-2 receptor antibodies
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
AU6904100A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor beta chain gene
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU2552300A (en) Heating means
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU1773501A (en) Human single nucleotide polymorphisms
AU4968700A (en) Animal stall with gate adapted for goading the animal
AU7706000A (en) Drug target isogenes: polymorphisms in the interleukin-1 beta gene
AU3269401A (en) Simultaneous hybridization/priming for snp analysis
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene
AU5058800A (en) Continuous transporter
MXPA01012500A (en) Gene therapy products.

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase